-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Immuneering Corp quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
- Immuneering Corp Return On Equity for the quarter ending September 30, 2024 was -79.2 %, a 63.6% decline year-over-year.
- Immuneering Corp annual Return On Equity for 2023 was -52.5 %, a 32.3% decline from 2022.
- Immuneering Corp annual Return On Equity for 2022 was -39.7 %, a 25.9% increase from 2021.
- Immuneering Corp annual Return On Equity for 2021 was -53.5 %, a 148% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)